Phenylephrine Efficacy Studies Inconclusive, FDA’s Monograph Division Says
This article was originally published in The Tan Sheet
Executive Summary
Studies originally used to support phenylephrine efficacy under the OTC cold/cough monograph were insufficient "to provide a convincing demonstration of effectiveness," according to briefing materials prepared by FDA researchers for a Dec. 14 meeting of the Nonprescription Drugs Advisory Committee
You may also be interested in...
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
FDA's Nonprescription Drugs Advisory Committee recommends additional studies on phenylephrine efficacy for treatment of nasal congestion, although members say current data support the efficacy of the OTC cough/cold ingredient
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
FDA's Nonprescription Drugs Advisory Committee recommends additional studies on phenylephrine efficacy for treatment of nasal congestion, although members say current data support the efficacy of the OTC cough/cold ingredient
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
FDA's Nonprescription Drugs Advisory Committee recommends additional studies on phenylephrine efficacy for treatment of nasal congestion, although members say current data support the efficacy of the OTC cough/cold ingredient